BiotechTubeBiotechTube
Home/Vertex Pharmaceuticals/Sangeeta Bhatia
SB

Sangeeta Bhatia

Board Member

Vertex Pharmaceuticals

Therapeutic Areas

Cystic FibrosisSickle Cell DiseaseBeta ThalassemiaPain ManagementDiabetesKidney Disease

Vertex Pharmaceuticals Pipeline

DrugIndicationPhase
Trikafta (elexacaftor/tezacaftor/ivacaftor)Cystic FibrosisApproved
Kalydeco (ivacaftor)Cystic FibrosisApproved
Orkambi (lumacaftor/ivacaftor)Cystic FibrosisApproved
Symdeko (tezacaftor/ivacaftor)Cystic FibrosisApproved
CTX001Sickle Cell DiseasePhase 3
VX-548Acute PainPhase 3
VX-150Painful Diabetic Peripheral NeuropathyPhase 2
VX-880Type 1 DiabetesPhase 1/2

Leadership Team at Vertex Pharmaceuticals

RK
Reshma Kewalramani
Chief Executive Officer
CW
Charles Wagner
Chief Financial Officer
CB
Carmen Bozic
Chief Medical Officer
DA
David Altshuler
Chief Scientific Officer
BS
Bastiano Sanna
Chief of Cell and Genetic Therapies
SA
Stuart Arbuckle
Chief Commercial Officer
JC
Jeffrey Chodakewitz
Chief Medical Officer, Non-CF
BD
Bruce Downey
Board Member
AG
Alan Garber
Board Member
View full Vertex Pharmaceuticals profile